Skip to main content

Table 3 Summary of Previous Antipsychotics Treatment Received for Consecutive 3 Months

From: Effects of paliperidone extended release on the symptoms and functioning of schizophrenia

Antipsychotic Treatments

Overall

(N = 480)

ITT

(N = 426)

Oral Risperidone

224 (46.67%)

207 (48.59%)

Olanzapine

52 (10.83%)

49 (11.50%)

Quetiapine

35 (7.29%)

32 (7.51%)

Aripiprazole

30 (6.25%)

28 (6.57%)

Clozapine

14 (2.92%)

10 (2.35%)

Risperdal CONSTA

3 (0.63%)

1 (0.23%)

Other

125 (26.04%)

110 (25.82%)